Phreesia, Inc. (NYSE:PHR) General Counsel Sells $86,955.60 in Stock

Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman sold 3,495 shares of the company’s stock in a transaction dated Wednesday, December 18th. The shares were sold at an average price of $24.88, for a total value of $86,955.60. Following the sale, the general counsel now owns 116,296 shares in the company, valued at approximately $2,893,444.48. The trade was a 2.92 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Phreesia Stock Performance

Shares of Phreesia stock traded down $0.17 on Thursday, hitting $23.84. 379,492 shares of the company’s stock were exchanged, compared to its average volume of 451,149. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.77 and a current ratio of 1.74. The company has a 50-day simple moving average of $20.66 and a 200-day simple moving average of $21.90. The stock has a market capitalization of $1.39 billion, a PE ratio of -16.22 and a beta of 0.98. Phreesia, Inc. has a 1 year low of $17.07 and a 1 year high of $29.16.

Phreesia (NYSE:PHR) last announced its quarterly earnings data on Monday, December 9th. The company reported ($0.25) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The firm had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. During the same period last year, the firm earned ($0.58) EPS. The company’s revenue was up 16.6% on a year-over-year basis. As a group, equities analysts anticipate that Phreesia, Inc. will post -1.16 EPS for the current year.

Institutional Investors Weigh In On Phreesia

A number of institutional investors have recently added to or reduced their stakes in PHR. Franklin Resources Inc. lifted its holdings in shares of Phreesia by 3.0% in the third quarter. Franklin Resources Inc. now owns 1,497,631 shares of the company’s stock worth $31,495,000 after buying an additional 42,973 shares in the last quarter. Geode Capital Management LLC grew its stake in Phreesia by 4.7% during the third quarter. Geode Capital Management LLC now owns 1,245,797 shares of the company’s stock valued at $28,397,000 after acquiring an additional 55,934 shares in the last quarter. M&T Bank Corp increased its holdings in Phreesia by 4.6% in the 3rd quarter. M&T Bank Corp now owns 35,127 shares of the company’s stock valued at $801,000 after acquiring an additional 1,535 shares during the last quarter. Barclays PLC increased its holdings in Phreesia by 83.6% in the 3rd quarter. Barclays PLC now owns 94,929 shares of the company’s stock valued at $2,163,000 after acquiring an additional 43,225 shares during the last quarter. Finally, XTX Topco Ltd purchased a new stake in Phreesia in the 3rd quarter worth $247,000. 92.10% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on PHR shares. DA Davidson reiterated a “buy” rating and issued a $32.00 price objective on shares of Phreesia in a research note on Thursday, September 5th. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $23.00 price objective on shares of Phreesia in a research note on Friday, September 27th. JPMorgan Chase & Co. lifted their target price on Phreesia from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Monday, September 9th. Truist Financial upped their price objective on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Finally, Needham & Company LLC reaffirmed a “buy” rating and issued a $29.00 price objective on shares of Phreesia in a research report on Tuesday, December 10th. One research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Phreesia currently has an average rating of “Moderate Buy” and an average target price of $29.33.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.